NASDAQ:LFMD

LifeMD (LFMD) Stock Price, News & Analysis

LifeMD logo
$1.60 -0.11 (-6.18%)
Closing price 11/19/2026 04:00 PM Eastern
Extended Trading
$1.60 0.00 (0.00%)
As of 11/19/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About LifeMD Stock (NASDAQ:LFMD)

Advanced

Key Stats

Today's Range
$1.53
▼
$1.74
50-Day Range
$1.60
▼
$3.44
52-Week Range
$1.53
▼
$5.38
Volume
1.24 million shs
Average Volume
1.26 million shs
Market Capitalization
$77.09 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.71
Consensus Rating
Moderate Buy

Company Overview

LifeMD, Inc. is a virtual healthcare company that connects patients with medical providers through its telehealth platform. Its services include virtual primary care and specialty care, with offerings in areas such as men’s health and weight management.

The company operates the LifeMD and Rex MD brands and supports care through online consultations, treatment plans and, when prescribed, medication. Service availability and treatment options may vary by state and individual patient needs.

LifeMD serves patients in the United States. The company was previously known as Conversion Labs and adopted the LifeMD name in 2021.

AI Generated. May Contain Errors.

LifeMD Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
54th Percentile Overall Score

LFMD MarketRank™: 
2.68608636052 of 5 stars

LifeMD scored higher than 54% of companies evaluated by MarketBeat, and ranked 428th out of 845 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    LifeMD has received a consensus rating of Moderate Buy. The company's average rating score is 2.70, and is based on no strong buy ratings, 8 buy ratings, 1 hold rating, and 1 sell rating.

  • Upside Potential

    LifeMD has a consensus price target of $6.71, representing about 321.0% upside from its current price of $1.60.

  • Amount of Analyst Coverage

    LifeMD has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about LifeMD's stock forecast and price target.
  • Earnings Growth

    Earnings for LifeMD are expected to grow in the coming year, from ($0.48) to ($0.06) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of LifeMD is -26.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of LifeMD is -26.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    18.14% of the float of LifeMD has been sold short.
  • Short Interest Ratio / Days to Cover

    LifeMD has a short interest ratio ("days to cover") of 10.82, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in LifeMD has recently decreased by 2.16%, indicating that investor sentiment is improving.
  • Dividend Yield

    LifeMD does not currently pay a dividend.

  • Dividend Growth

    LifeMD does not have a long track record of dividend growth.

  • News Sentiment

    LifeMD has a news sentiment score of -0.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.39 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 11 news articles for LifeMD this week, compared to 2 articles on an average week.
  • Search Interest

    8 people have searched for LFMD on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • MarketBeat Follows

    4 people have added LifeMD to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, LifeMD insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    17.22% of the stock of LifeMD is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    35.52% of the stock of LifeMD is held by institutions.

  • Read more about LifeMD's insider trading history.
Receive LFMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeMD and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LFMD Stock News Headlines

Financial Analysis: LifeMD (LFMD) & Its Peers
LifeMD: 3 Key Takeaways for Long-Term Investors
ELON + YOU + DECEMBER 8TH
Elon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th. A free Masterclass claims to reveal what Musk filed with regulators and why he's working to keep it quiet.tc pixel
LifeMD (LFMD) Q3 2026 Earnings Call Transcript
LifeMD, Inc. (LFMD) Q3 2026 Earnings Call Transcript
LifeMD Reports Third Quarter 2026 Results
See More Headlines

LFMD Stock Analysis - Frequently Asked Questions

LifeMD's stock was trading at $3.41 on January 1st, 2026. Since then, LFMD shares have decreased by 53.2% and is now trading at $1.5950.

LifeMD, Inc. (NASDAQ:LFMD) released its quarterly earnings data on Thursday, November, 12th. The company reported ($0.11) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.14) by $0.03. The company had revenue of $44.63 million for the quarter, compared to analyst estimates of $48.84 million. LifeMD had a negative net margin of 0.25% and a negative trailing twelve-month return on equity of 188.63%.
Read the conference call transcript
.

Top institutional investors of LifeMD include State Street Corp (2.67%), Marshall Wace LLP (1.68%), Goldman Sachs Group Inc. (0.48%) and Cibc World Market Inc. (0.13%). Insiders that own company stock include Justin Schreiber, Nicholas P Alvarez, Marc David Benathen, Jessica Friedeman, Stefan Galluppi and Eric Harold Yecies.
View institutional ownership trends
.

Shares of LFMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that LifeMD investors own include NVIDIA (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD), CrowdStrike (CRWD), Intel (INTC), Palantir Technologies (PLTR) and Hims & Hers Health (HIMS).

Company Calendar

Last Earnings
11/12/2026
Today
11/19/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Services
Current Symbol
NASDAQ:LFMD
CIK
948320
Fax
N/A
Employees
384
Year Founded
2016

Price Target and Rating

High Price Target
$10.00
Low Price Target
$3.00
Potential Upside/Downside
+321.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.70
Research Coverage
10 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.06)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$14.35 million
Net Margins
-0.25%
Pretax Margin
-11.34%
Return on Equity
-188.63%
Return on Assets
-32.24%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.80
Quick Ratio
0.63

Sales & Book Value

Annual Sales
$194.05 million
Price / Sales
0.40
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.01) per share
Price / Book
-159.50

Miscellaneous

Outstanding Shares
48,330,000
Free Float
40,011,000
Market Cap
$77.09 million
Optionable
Optionable
Beta
2.19

Social Links

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (NASDAQ:LFMD) was last updated on 11/19/2026 by MarketBeat.com Staff.
From Our Partners